Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Agents that can modulate colonic environment and control dysregulated signaling are being evaluated for their chemopreventive potential in colon cancer. Ursodeoxycholate (UDCA) has shown chemopreventive potential in preclinical and animal models of colon cancer, but the mechanism behind it remains unknown. Here biological effects of UDCA were examined to understand mechanism behind its chemoprevention in colon cancer. Our data suggests that UDCA can suppress growth in a wide variety of cancer cell lines and can induce low level of apoptosis in colon cancer cells. We also found that UDCA treatment induces alteration in morphology, increased cell size, upregulation of cytokeratin 8, 18 and 19 and E‐cadherin, cytokeratin remodeling and accumulation of lipid droplets, suggesting that UDCA induces differentiation in colon carcinoma cells. Our results also suggest significant differences in UDCA and sodium butyrate induced functional differentiation. We also report for the first time that UDCA can induce senescence in colon cancer cells as assessed by flattened, spread out and vacuolated morphology as well as by senescence marker β‐galactosidase staining. We also found that UDCA inhibits the telomerase activity. Surprisingly, we found that UDCA is not a histone deacytylase inhibitor but instead induces hypoacetylation of histones unlike hyperacetylation induced by sodium butyrate. Our results also suggest that, although UDCA induced senescence is p53, p21 and Rb independent, HDAC6 appears to be important in UDCA induced senescence. In summary, our data shows that UDCA modulates chromatin by inducing histone hypoacetylation and induces differentiation and senescence in colon cancer cells. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770
Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression
Smith, J. R., & Pereira-Smith, O. M. (1996) · Science · doi:10.1126/science.273.5271.63 · Cited by 547
Mechanisms of cellular senescence in human and mouse cells.
Itahana, K., Campisi, J., & Dimri, G. P. (2004) · Biogerontology · doi:10.1023/b:bgen.0000017682.96395.10 · Cited by 338 · cited 1×
“have associated induction of senescence with histone hypoacetylation.(75) Similarly, the lack of expression of telomerase has been correlated with hypoacetylation of AcH3 and AcH4.”
BackgroundSenescence, apoptosis and therapy — cutting the lifelines of cancer
Schmitt, C. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1044 · Cited by 295
Ogryzko, V. V., Hirai, T. H., Russanova, V. R., Barbie, D. A., & Howard, B. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5210 · Cited by 268
Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma Recurrence
Alberts, D. S., Martínez, M. E., Hess, L. M., Einspahr, J. G., Green, S. B., Bhattacharyya, A. K., Guillen, J., Krutzsch, M., Batta, A. K., Salen, G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji144 · Cited by 247 · cited 2×
“The presented results also support the results of the phase III clinical trial that revealed that UDCA can reduce the degree of dysplasia in colonic polyps.(31)”
ResultThe emerging role of epigenetics in cellular and organismal aging
Bandyopadhyay, D., & Medrano, E. E. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.009 · Cited by 104
Research works printed but not linked: 68
- 10.3322/canjclin.55.1.10 · DOI · Paper page
- 10.1002/ijc.2910150411 · DOI · Paper page
- 10.1093/carcin/18.10.1863 · DOI
- 10.1093/ajcn/53.4.1064S · DOI
- 10.1093/jnci/87.23.1760 · DOI · Paper page
- 10.1056/NEJM199901143400204 · DOI · Paper page
- 10.1002/1097-0142(197706)39:6<2533::AID-CNCR2820390634>3.0.CO;2-X · DOI · Paper page
- 10.1007/BF02554556 · DOI
- 10.1016/0016-5085(93)90846-5 · DOI · Paper page
- Cohen BI, 1981, Effects of bile acids on colon carcinogenesis in rats treated with carcinogens, Cancer Res, 41, 3759
- 10.1007/BF02535855 · DOI · Paper page
- 10.1074/jbc.M908890199 · DOI · Paper page
- 10.1038/sj.cdd.4400395 · DOI
- 10.1074/jbc.273.4.2424 · DOI · Paper page
- 10.1093/carcin/22.1.35 · DOI · Paper page
- 10.1016/S1388-1981(02)00190-7 · DOI
- Zheng ZY, 1995, Bile acid activation of the GADD153 promoter and of p53‐independent apoptosis: relevance to colon cancer, Cell Death Differ, 3, 407
- 10.1016/S0027-5107(01)00195-6 · DOI · Paper page
- 10.1016/j.bbalip.2005.04.006 · DOI
- Garewal H, 1996, Reduced bile acid‐induced apoptosis in ‘normal’ colorectal mucosa: a potential biological marker for cancer risk, Cancer Res, 56, 1480
- 10.3109/01913129509064227 · DOI · Paper page
- Earnest D, 1994, Chemoprevention of azoxymethane‐induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid, Cancer Res, 54, 5071
- Wali R, 1995, Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C‐α, ‐βII, and ‐ζ, Cancer Res, 55, 5257
- 10.1053/j.gastro.2004.06.003 · DOI
- 10.1080/01635589809514689 · DOI · Paper page
- 10.1093/jn/134.2.483 · DOI
- 10.1207/s15327914nc5101_15 · DOI
- 10.1053/jhep.2003.50311 · DOI · Paper page
- 10.7326/0003-4819-134-2-200101160-00008 · DOI · Paper page
- 10.1053/gast.2003.50156 · DOI · Paper page
- 10.1016/0277-5379(84)90194-9 · DOI
- 10.1002/(SICI)1097-0215(19971210)73:6<924::AID-IJC27>3.0.CO;2-2 · doi:10.1002/(sici)1097-0215(19971210)73:6<924::aid-ijc27>3.0.co;2-2
- 10.1016/S1471-4892(03)00081-X · DOI
- 10.1002/1097-0142(19830101)51:1<9::AID-CNCR2820510104>3.0.CO;2-4 · DOI
- 10.1182/blood.V80.10.2604.2604 · DOI · Paper page
- 10.1073/pnas.93.12.5705 · DOI · Paper page
- 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7 · DOI · Paper page
- Roninson IB, 2003, Tumor cell senescence in cancer treatment, Cancer Res, 63, 2705
- 10.1016/S0959-8049(02)00497-5 · DOI
- te Poele RH, 2002, DNA damage is able to induce senescence in tumor cells in vitro and in vivo, Cancer Res, 62, 1876
- 10.1158/0008-5472.CAN-03-0820 · DOI
- 10.1016/j.mrfmmm.2005.02.029 · DOI · Paper page
- 10.4161/cbt.190 · DOI · Paper page
- 10.1016/j.ccr.2005.05.025 · DOI · Paper page
- 10.1158/1078-0432.CCR-04-0455 · DOI · Paper page
- 10.1074/jbc.M003106200 · DOI · Paper page
- 10.1042/bj3560481 · doi:10.1042/bj3560481 · Paper page
- 10.1016/S0304-3835(98)00242-0 · DOI
- ParasassiT BrunelliR Bracci‐LaudieroL GrecoG GustafssonAC KrasnowskaEK LundebergJ LundebergT PittalugaE RomanoMC SerafinoA.Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms.2005;12:1285–96. · DOI
- 10.1089/dna.2005.24.21 · DOI
- 10.1023/A:1024043302583 · DOI
- 10.1038/sj.onc.1206625 · doi:10.1038/sj.onc.1206625
- 10.1016/S1097-2765(00)80047-7 · DOI · Paper page
- Fornari FA, 1994, Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c‐myc expression in MCF‐7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin, Cell Growth Differ, 5, 723
- Sovova V, 2003, Alterations in mitochondria function and morphology in HT29 cells upon conditions inducing differentiation and apoptosis, Int J Oncol, 23, 1755
- 10.1046/j.1432-1327.2000.01731.x · DOI · Paper page
- 10.1016/S0006-291X(02)00365-0 · DOI
- Deng G, 1992, Transcriptional regulation of the human placental‐like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate, Cancer Res, 52, 3378
- 10.1016/0014-4827(65)90211-9 · DOI · Paper page
- 10.1073/pnas.92.20.9363 · DOI · Paper page
- 10.1667/RR3280 · DOI
- 10.1002/ijc.1448 · DOI · Paper page
- Van Lint C, 1996, The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation, Gene Expr, 5, 245
- 10.1093/hmg/10.7.693 · DOI · Paper page
- 10.1002/bies.1117 · DOI · Paper page
- 10.1034/j.1600-0749.2002.02036.x · DOI · Paper page
- 10.1158/0008-5472.CAN-05-1715 · DOI · Paper page
- 10.1016/0531-5565(95)00022-4 · DOI
Cited by
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults
Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070803 · Cited by 642
Cancer-promoting effects of microbial dysbiosis
Sheflin, A. M., Whitney, A. K., & Weir, T. L. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0406-0 · Cited by 301
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
Ogrodnik, M., Salmonowicz, H., & Gladyshev, V. N. (2019) · Aging Cell · doi:10.1111/acel.12841 · Cited by 184
Metadata
- Authors
- Akare, S., Jean‐Louis, S., Chen, W., Wood, D. J., Powell, A. A., & Martinez, J. D.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-10-26
- Volume
- 119
- Issue
- 12
- Pages
- 2958-2969
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1980045905
- Cited by
- 55
- References
- 9
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.